Selective decontamination of the digestive tract reduces hospital mortality in mechanically ventilated ICU adults

This systematic review and meta-analysis synthesized data from 30 of 32 randomized controlled trials involving 27,332 participants to assess the impact of selective decontamination of the digestive tract (SDD) on outcomes in critically ill patients. The study population consisted of adults receiving mechanical ventilation in an intensive care unit (ICU). The intervention involved SDD protocols, while the comparator group received standard care or placebo. The analysis focused primarily on hospital mortality as the main endpoint of interest.

The primary outcome results demonstrated a pooled estimated relative risk of 0.91 for hospital mortality. The 95% credible interval for this effect size ranged from 0.82 to 0.99. This statistical finding indicates a reduction in the risk of death within the hospital setting for patients treated with SDD compared to those receiving standard care or placebo. The direction of the effect favored the SDD intervention, showing lower hospital mortality rates in the treated group.

Safety and tolerability findings were not reported in the available data for this meta-analysis. There were no specific adverse event rates, serious adverse event counts, or discontinuation rates provided in the input evidence. Consequently, the safety profile of SDD in this specific context remains undefined by the data included in this synthesis. Tolerability data were also not reported, limiting the ability to assess patient comfort or treatment adherence based on side effects.

The certainty of the evidence was quantified with a 99.2% posterior probability that SDD was associated with lower hospital mortality. This high probability suggests a strong statistical association, yet the synthesis relies on the aggregation of multiple randomized trials rather than a single large-scale primary trial. The input data did not provide specific p-values for individual studies, nor did it detail the specific dosing protocols or antibiotic regimens used within the SDD interventions across the various trials.

Key methodological limitations and potential biases were not explicitly detailed in the provided input data. The absence of reported limitations means that sources of heterogeneity between the 30 contributing trials, such as variations in SDD regimens or ICU practices, could not be fully characterized. Funding sources and potential conflicts of interest were also not reported, which is a standard consideration when evaluating the robustness of systematic reviews.

Clinical implications suggest that SDD may be a viable strategy to reduce hospital mortality in mechanically ventilated ICU adults. However, the lack of reported safety data necessitates caution when considering implementation in practice. The results should be interpreted alongside existing guidelines and local antibiotic stewardship policies. Further research is needed to clarify the safety profile and to determine if specific SDD regimens yield better outcomes than others.

Several questions remain unanswered regarding the long-term effects of SDD and its impact on specific infectious disease outcomes beyond mortality. The absence of data on adverse events prevents a complete risk-benefit analysis for clinicians. Additionally, the specific mechanisms by which SDD reduces mortality in this population require further investigation. The input data did not include secondary outcomes related to length of stay, ICU-free days, or specific infection rates, leaving these important clinical metrics unexplored in this synthesis.